RIME Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RIME is not a good buy right now. The prevailing trend is bearish (price below key moving averages and below the pivot), proprietary trading signals show no entry, and the statistical pattern outlook points to further downside over the next week/month. With an impatient profile and no “must-buy-now” signal or clear near-term catalyst that changes fundamentals, the better call is to avoid/sell rather than buy at $0.8779.
Trend/structure: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating the stock is in a longer-term downtrend. Momentum: Mixed-to-weak. MACD histogram is positive (0.0236) but positively contracting, suggesting upside momentum is fading rather than accelerating. RSI(6) ~42.7 is neutral-to-soft (not oversold). Levels: Current price $0.8779 is below the pivot (0.937), keeping near-term bias negative. Key support is S1 ~0.795 (then S2 ~0.708). Resistance is R1 ~1.078 (then R2 ~1.165). Pattern-based probability: Similar-candlestick analogs imply ~+1.05% next day, but -2.43% next week and -8.39% next month—skewing the near-term risk/reward against chasing now.
Intellectia Proprietary Trading Signals
Upcoming visibility/catalyst: Company showcasing SemiCab Apex AI SaaS at the 2026 Retail Supply Chain Conference (news dated 2026-01-29), which can help awareness and pipeline.
Market tailwinds narrative: U.S. full-truckload market projected growth to $535B by 2030, and SemiCab’s pitch targets reducing empty-miles losses (large addressable problem).
on 2026-02-18 pre-market; for a micro-cap, earnings can be a major volatility event.
Latest reported quarter: 2025/Q3. Growth: Revenue increased to $1.744M (+1273.23% YoY), showing strong top-line acceleration off a small base. Profitability: Net income fell to -$2.962M (down -347.87% YoY) and EPS to -$1.15 (down -104.38% YoY), indicating losses widened materially. Margins: Gross margin was -20.13%, meaning the company is currently operating with negative gross profitability—an unfavorable quality-of-revenue signal even with rapid growth. Bottom line: The quarter shows high growth but deteriorating earnings/margins, which is not supportive for an “impatient buy-now” setup.
No analyst rating or price target change data was provided, suggesting limited/absent Street coverage. Wall Street-style pros/cons based on available info: Pros—large logistics TAM and a clear efficiency-focused product narrative (Apex AI SaaS, open API integrations). Cons—micro-cap scale, widening losses, and negative gross margin; without visible analyst upgrades/targets, there’s no external validation catalyst in the data.
